Elliott Fegelman, MD, on Bariatric Surgery: A Treatment for Diabetes, Obesity, and Other Cardiometabolic Conditions

Dr Elliott Fegelman, therapeutic area lead for Metabolics at Johnson & Johnson Innovation, discusses bariatric surgery as a treatment for cardiometabolic conditions, the risks and benefits of surgery, as well as the research that has led to this recognition.

For information about the STAMPEDE trial, click here.

Find more information about bariatric surgery at our Medical Resource Center.

Submit Feedback